MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

Search

Baxter International Inc

Suletud

SektorTervishoid

31.04 0.13

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

30.89

Max

31.12

Põhinäitajad

By Trading Economics

Sissetulek

552M

64M

Müük

-128M

2.6B

P/E

Sektori keskmine

124.8

40.527

Dividenditootlus

2.24

Kasumimarginaal

2.438

Töötajad

38,000

EBITDA

501M

325M

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

+13.58% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

2.24%

2.40%

Järgmine tulemuste avaldamine

5. aug 2025

Järgmine dividendimakse kuupäev

30. sept 2025

Järgmine aktsia dividendi kuupäev (ex-date)

29. aug 2025

Turustatistika

By TradingEconomics

Turukapital

-175M

16B

Eelmine avamishind

30.91

Eelmine sulgemishind

31.04

Tehniline skoor

By Trading Central

Kindlus

Weak Bullish Evidence

Baxter International Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

5. juuli 2025, 04:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

4. juuli 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

4. juuli 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

4. juuli 2025, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

4. juuli 2025, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

4. juuli 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

4. juuli 2025, 16:20 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

4. juuli 2025, 16:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

4. juuli 2025, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

4. juuli 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

4. juuli 2025, 15:57 UTC

Market Talk

Base Metal Prices Fall in Thin, Risk-off Trading -- Market Talk

4. juuli 2025, 15:49 UTC

Market Talk

Gold Futures Set to End Week Flat After Mixed Jobs Report -- Market Talk

4. juuli 2025, 15:49 UTC

Omandamised, ülevõtmised, äriostud

Credit Agricole: Deal Will Have a Negative Impact of Approximately 30 Basis Points on the Fully-Loaded CET1 Ratio

4. juuli 2025, 15:49 UTC

Omandamised, ülevõtmised, äriostud

Credit Agricole: Transaction Is Consistent With Targets in Terms of Return of Investment, Return on Tangible Equity

4. juuli 2025, 15:49 UTC

Omandamised, ülevõtmised, äriostud

Credit Agricole Received All Required Authorizations

4. juuli 2025, 15:48 UTC

Omandamised, ülevõtmised, äriostud

Credit Agricole: CACEIS and Santander Are Maintaining Their Long-Term Partnership

4. juuli 2025, 15:47 UTC

Omandamised, ülevõtmised, äriostud

Credit Agricole: Agreement Was Announced on Dec. 19

4. juuli 2025, 15:47 UTC

Omandamised, ülevõtmised, äriostud

Credit Agricole Now Controls 100% of the Share Capital of CACEIS

4. juuli 2025, 15:46 UTC

Omandamised, ülevõtmised, äriostud

Credit Agricole Completes Acquisition of Santander's 30.5% Stake in CACEIS

4. juuli 2025, 14:30 UTC

Omandamised, ülevõtmised, äriostud

Rocky Shore Closes Hemlo Area Claims Sale to Barrick Mining Unit for C$975,000 Cash

4. juuli 2025, 13:53 UTC

Market Talk

Polish Zloty Faces Hit From Prospect of Further Rate Cuts -- Market Talk

4. juuli 2025, 13:41 UTC

Market Talk

Japanese Yen Could Receive Boost From Increased Rate-Hike Bets -- Market Talk

4. juuli 2025, 13:41 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

4. juuli 2025, 13:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

4. juuli 2025, 12:37 UTC

Market Talk

Fund Manager Roundup: U.S. Treasurys in Focus Amid Rising Debt

4. juuli 2025, 12:37 UTC

Market Talk

Fund Manager Roundup: U.S. Treasurys in Focus -2-

4. juuli 2025, 12:30 UTC

Market Talk

Fund Manager Roundup: U.S. Tariff Deadline Key for Dollar Outlook, U.K. Fiscal Risks In Focus for Pound

4. juuli 2025, 12:15 UTC

Market Talk

Targeted Tariffs Would Likely Support Dollar -- Market Talk

4. juuli 2025, 12:13 UTC

Market Talk

Further Pause in Tariffs Would Have Unclear Impact on Dollar -- Market Talk

4. juuli 2025, 12:02 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

Võrdlus sarnastega

Hinnamuutus

Baxter International Inc Prognoos

Hinnasiht

By TipRanks

13.58% tõus

12 kuu keskmine prognoos

Keskmine 35.22 USD  13.58%

Kõrge 40 USD

Madal 28 USD

Põhineb 10 Wall Streeti analüütiku instrumendi Baxter International Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

10 ratings

3

Osta

6

Hoia

1

Müü

Tehniline skoor

By Trading Central

30.475 / 31.345Toetus ja vastupanu

Lühikene perspektiiv

Weak Bullish Evidence

Keskpikk perspektiiv

Bearish Evidence

Pikk perspektiiv

Bearish Evidence

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Baxter International Inc

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.